Pelage Pharmaceuticals News and Activities

Acquisition, funding and merger involving Pelage Pharmaceuticals.

• Pelage Pharmaceuticals has just announced a $120 Million fundraising (posted on October 16 2025).

View the org chart displaying its 10 main executives

Most searched biographies at Pelage Pharmaceuticals

• Daniel Gil, Chief Executive Officer
• Cathy Friedman, Chairman of the Board
• Richard Heyman, Director

Popular executive movements at Pelage Pharmaceuticals

• Nathan Wheeler, who was Vice President and Head of Operations, is promoted to Chief Operating Officer  (posted on February 24 2026).
• Lisa Sherman, who was Senior Director, Clinical Operations, is promoted to Vice President, Head of Clinical Operations  (posted on February 24 2026).
• Maykin Ho has joined the company as Director  (posted on February 24 2026).

Click here to view some more movements at Pelage Pharmaceuticals

Create your alert
to follow the executive moves at Pelage Pharmaceuticals.

Pelage Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Pelage Pharmaceuticals

Social media about Pelage Pharmaceuticals

• Pelage Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Pelage Pharmaceuticals on LinkedIn, X (Twitter) & YouTube